Quality of life and home enteral tube feeding: a French prospective study in patients with head and neck or oesophageal cancer by Roberge, C et al.
The negative impact of weight loss upon morbidity and mortality
of cancer patients is well known. It may decrease the response to
chemotherapy as well as the tolerance to both radio and
chemotherapy (Dewys et al, 1980; Vigano et al, 1994). Artificial
nutrition can limit the risk of malnutrition although it is unable to
restore a severely altered nutritional state (Lipman, 1991; Lopez et
al, 1994; Société Française de Nutrition Entérale et Parentérale et
Société Française d’Anesthésie Réanimation, 1995; Shike, 1996;
Souba, 1997; Barber et al, 1998). Enteral tube feeding (ETF) is the
method of choice in patients with functional digestive tract
(Campos et al, 1990; Boyd and Beeken, 1994; Bozetti, 1994;
Société Française de Nutrition Entérale et Parentérale et Société
Française d’Anesthésie Réanimation, 1995). During short-period
ETF, nasogastric tube is generally used for diet administration.
Gastrostomy and jejunostomy are indicated in prolonged or
permanent ETF only (Société Française de Nutrition Entérale et
Parentérale et Société Française d’Anesthésie Réanimation, 1995).
ETF-related complications are uncommon, the most frequent
being diarrhoea (Coben et al, 1994; Société Française de Nutrition
Entérale et Parentérale et Société Française d’Anesthésie
Réanimation, 1995). Acute aspiration pneumonia is rare and can
easily be avoided (Lopez et al, 1994).
During the last 15 years, home enteral tube feeding (HETF) has
become a daily practice (Sami et al, 1990; Howard, 1993; Elia,
1995). Compared with home parenteral nutrition, HETF is a
simpler and cheaper technique, with fewer related complications
(Detsky et al, 1986; Elia, 1994; Howard et al, 1995). In France,
HETF is not charged to the patient (i.e. it is totally reimbursed by
the social security) providing that nutrition lasts at least 1 month
(Ministère de la Solidarité, de la Santé et de la Protection Sociale,
1988; Ministère des Affaires Sociales, de la Santé et de la Ville,
1993).
Quality of life evaluation has become essential in all situations
where the disease or its treatment are likely to induce physical,
emotional, cognitive, social, family or professional impairment
(Launois, 1994; Osoba, 1994; Grindel et al, 1996). Eating is not
only considered a vital function but also a daily pleasure as well as
a social tradition. A patient with HETF is nourished but does not
eat. The meal is limited to its functional role; its social role disap-
pears and the patient no longer gets pleasure from it. In addition,
the tube can induce discomfort; it is also a reason for corporal
image change. One can, therefore, speculate that these modifica-
tions interfere with patient’s quality of life. In other words, it is
likely that a close relationship exists between quality of life and
HETF tolerance when considering that HETF intolerance can
bring an end to parenteral nutrition (Société Française de Nutrition
Entérale et Parentérale et Société Française d’Anesthésie
Réanimation, 1995).
Quality of life and tolerance in patients with HETF have rarely
been explored (Elia, 1994; Malone, 1994; Grindel et al, 1996). In
studies dealing with this subject, measurements were made using
non-validated instruments (Peteet et al, 1981; Rains, 1981; Nelson
et al, 1986; Sami et al, 1990) or using instruments validated for
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was restricted to physical or psychological functioning or to symp-
toms reported by patients (Peteet et al, 1981; Rains, 1981; Sami et
al, 1990); HETF-related discomfort has been studied in hospital-
ized patients (Padilla et al, 1979; Bruning et al, 1988) while HETF
tolerance has been mentioned only in papers dealing with personal
views (Gulledge et al, 1987; Srp et al, 1989) or in reports on social
and family impairments encounted by families or carers of 
children with HETF (Holden et al, 1991; Michaelis et al, 1992).
The aim of the present study was to evaluate the impact of
HETF on quality of life in patients suffering from head and neck or
oesophageal cancer, two cancers that usually necessitate enteral
feeding. Our area is also the region where the incidence of these
two cancers is among the highest in France (Parkin et al, 1997).
PATIENTS AND METHODS
Patient selection
Eligible patients fulfilled the following criteria: head and neck or
oesophageal cancer; treated at the Centre François Baclesse for
first line treatment or relapse; with HETF starting in the
January–June 1997 period; with informed consent to participate in
the study. Thirty-nine (27%) patients among the 146 patients who
had enteral nutrition during the study period, were eligible for
enrolment in the study. Overall, nine physicians and five dieticians
participated in the study.
Study measures
The study was conducted from January to July 1997. The French
language validated self-administered questionnaire of the
European Organization for Research and Treatment of Cancer
(EORTC) QLQ-C30 core questionnaire (Aaronson et al, 1994)
was used to appreciate generic quality of life data. The head and
neck (H&N35) (Bjordal et al, 1999) and the oesophageal (OES24)
(Blazeby et al, 1996) modules developed by the EORTC were
added to evaluate the head and neck or oesophageal disease-
targeted measures of quality of life. The QLQ-C30 core question-
naire explores six functional areas: two concern the physical
aspect of functioning (physical and role functioning), three the
psychosocial functioning (emotional, cognitive and social func-
tioning), while the last one relates to quality of life in general. This
questionnaire also includes a number of multi-item scales and
single items assessing a range of physical symptoms (fatigue,
nausea and vomiting, pain, dyspnoea, sleep disturbance, appetite
loss, constipation and diarrhoea) and financial difficulties. A
detailed manual for scoring procedures has been published by the
EORTC (Fayers et al, 1995). For functional scales, scores
computed ranged from 0 to 100, with the higher scale score repre-
senting a higher level of functioning. For item scales relative to
physical symptoms and financial impact, scores computed ranged
from 0 to 100, with a higher score representing a higher level of
symptomatology or problems. The H&N35 and OES24 modules
only include items relative to physical symptoms. They concern
swallowing, pain, coughing and speech in both modules, nutri-
tional aspects, feeling ill, social function and body image/sexuality
in the H&N35 module, dysphagia, feeding difficulties, upper
digestive tract disorders, emotional aspect, dry mouth and taste in
the OES24 module. Two items (‘use of nutritional supplements’
and ‘use of feeding-tube’) of the H&N35 questionnaire were not
analysed because all patients had a feeding-tube and nutritional
supplements were never prescribed. The generic questionnaire and
the specific modules addressed the patient status the week before
interview. At the time of study, no questionnaire was available in
French to evaluate the tolerance of HETF, as well as its family and
social impact in these patients. Therefore, a second self-adminis-
tered questionnaire (60 items) was specifically developed and
tested prior to the study on ten patients. Most items covered in this
questionnaire were objective, concerning modality of feeding
technique, physical and psychological tolerance of HETF, and
items relating to demographic data, family and social relation-
ships. All items referred to the patient’s status 1 week and 4 weeks
after returning home. These self-administered questionnaires
(EORTC QLQ-C30 core questionnaire and specific modules, and
self-developed questionnaire) were usually completed within 
45 min. Clinical data were obtained from medical records. It
concerned tumour location, date of diagnosis, WHO performance
status, weight loss, date of start, date of end and type of initial
therapy (surgery, radiation therapy, chemotherapy, combined
modality), date of ETF start, clinical status at this date and
previous history of HETF. Although the questionnaires were
designed to be filled in by the patient, the protocol specified that a
representative (CR) should always assist the patient either at home
(day 7) or before or after a visit at Centre François Baclesse (day
28). However, two-thirds of patients completed the day-7 ques-
tionnaires at Centre François Baclesse because of planned follow-
up visit, biologic examination or radiation therapy.
Patient characteristics
Overall, 39 patients (38 males) were included in the study. The
mean age was 58 years (range 38–74). Eighty-four per cent were
married or lived as a couple. The last occupation was worker, qual-
ified worker or employee in 77% of the patients. At the time of the
study, however, 46% had retired. Patient medical characteristics
are listed in Table 1. Oesophageal cancer was present in four
patients only. HETF indication was first tumour care (28%) or
relapse (39%) in 67% of patients; in other patients it was given
because of treatment-related complication, mainly post-radiation
necrosis.
Enteral tube feeding
Nasogastric and gastrostomy tube was used in 80% and 20% of
patients respectively. Nasogastric tube consisted of small bore 
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Table 1 Patient medical characteristics at inclusion
Medical characteristics (n = 39) No %
Tumour localization
Mouth, tongue, oropharynx 24 61
Hypopharynx, larynx 11 29
Oesophagus 4 10
WHO performance status
Normal or quite normal activity (code 0, 1) 15 38
Bedridden ≤50% of the day (code 2) 22 57
Bedridden > 50% of the day (code 3) 2 5
Weight loss
³10% of body weight 23 60(4 mm) polyurethane tube. Gastrostomy tube was natural rubber
latex Foley tube surgically placed. An average daily caloric intake
of 2100 Kcal (Enterogil 500 Na 80®), i.e. caloric diet of 
500 Kcal/500 ml) was usually delivered in intermittent nutrient
intake (mean 4.4 per day, range 4–6). Additional water intake was
recommended including tube rinsing after each intake (100–150
ml) and 50–100 ml if the patient felt thirsty. Seventy-seven per
cent of patients had no previous experience of HETF. Education of
patient and his family was given before hospital discharge by dieti-
cians. It consisted in oral and written information during hospital-
ization and practical use of tube feeding the day of hospital
discharge. Written information included a description of the tech-
nique, specific recommendations and advice regarding problems
that can occur (i.e. thirst and hunger management, tube obstruc-
tion, diarrhoea, constipation…).
Statistical analysis
For statistical analysis of categorical data, the Fisher exact test
was used to compare independent data and the MacNemar test to
compare paired data. The Kruskal–Wallis test was used to
compare quantitative data. Changes between day-7 and day-28
scores were calculated as the difference between scores measured
at day 28 and those measured at day 7, patients being taken as
their own controls. Therefore, a positive difference of functional
scores represents an improvement while a negative difference of
symptom scores represents an improvement. The STATA and the
STATXACT statistical software packages were used (Cytel
Software Corporation, 1995; Stata Corp, 1996). Data was
prospectively stored at the Clinical Research Unit of the Centre
François Baclesse using a specific data management system
(Wartelle et al, 1983).
RESULTS
Self-reported health status at day 7
Results from the EORTC QLQ-C30 core questionnaire and those
from the H&N35 module are listed in Table 2. The results refer to
patient status during the first week after returning home.
Functional scales
Of the six QLQ-C30 functional scales, the physical scales were
scored the lowest, similar to those of global health status. None of
the scales measured correlated with either tumour localization or
treatment type.
Symptom scales
The nine QLQ-C30 symptom scores could be grouped into three
categories. Symptoms with low impact were nausea and vomiting,
constipation, diarrhoea and financial difficulties. Symptoms with
intermediate impact were pain, dyspnoea, insomnia and appetite
loss while fatigue was scored higher. The eight H&N35 symptom
scores were in the same range as those of the QLQ-C30, with nutri-
tional aspects and speech being associated with the higher scores.
Pain score of the QLQ-C30 and that of the H&N35 questionnaires
correlated (P = 0.04). Social functioning score of the QLQ-C30
questionnaire and that of social function of the H&N35 question-
naire were complementary. The OES24 questionnaire was
completed by the four patients with oesophageal carcinoma. Of the
ten symptoms explored, five (swallowing, nutritional aspects, pain,
coughing, and speech) are common to those of the H&N35 ques-
tionnaire. Scores reported by these four patients were similar to
those reported by the 35 patients with head and neck cancer except
for pain and coughing which were scored 0 by three patients.
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Table 2 EORTC QLQ-C30 and QLQ-H&N35 questionnaires for quality of life: scores at day 7 among 39
patients
Mean Mean
QLQ-C30 (n = 39) score s.d. H&N-35 (n = 35) score s.d.
Functional scalesa
Physical functioning 45 26
Role functioning 55 38
Emotional functioning 62 28
Cognitive functioning 77 25
Social functioning 62 34
Global health status/Qol 45 19
Symptom scales/itemsb Symptom scales/itemsb
Fatigue 62 29 Swallowing 28 28
Nausea and vomiting 18 30 Nutritional aspects (1) 46 24
Pain 36 32 Pain 33 27
Dyspnoea 38 38 Coughing 38 35
Insomnia 38 38 Feeling ill 21 27
Appetite loss 37 45 Social function (2) 37 31
Constipation 26 30 Speech 53 33
Diarrhoea 26 28 Body image/sexuality (3) 40 32
Financial difficulties 17 30
aHigher scores represent a higher level of functioning. bHigher scores represent a higher level of
symptomatology or difficulty. The QLQ-H&N35 symptom scales below refer to Bjordal et al (1999). (1) This
scale is composed of single items HNTE, HNOM, HNDR, HNSS + trouble eating (included in HNSO, social
eating) + scale SENSES. (2) This scale is composed of SOCIAL EATING (HNSO, items 20 to 22) + scale
SOCIAL CONTACT (HNSC, items 25 to 27). (3) This scale is composed of SOCIAL CONTACT (HNSC,
items 18 and 28) + scale SEXUALITY (HNSX).Tolerance of HETF at day 7
The medical prescription of HETF was well followed by the
patients as estimated through the number of meals (median 4) and
the caloric intake (median 2100 Kcal day–1). One-third of the
patients were able to feed with a mixed diet (ETF and grinding
food); these patients, however, did not display higher functional
scale scores than patients who were exclusively HETF fed. Half of
the patients required systematic help in setting up HETF. This help
was family provided in 90% of them, and corresponded to mother-
ing more than to a real need of physical or technical assistance.
Physical tolerance
Digestive complaints were reported by 18–43% of patients; they
were moderate and concerned nausea (18%), oesophageal reflux
(33%), meteorism (33%) and wind (43%). Moderate hunger was
reported by 44% of patients of whom 10% (four patients) sponta-
neously increased their caloric tube feeding intake. In contrast,
diurnal as well as nocturnal thirst was reported by 77% of patients.
Daily activities
HETF also induced discomfort in daily activities such as dressing
(40%) or washing (54%). In addition, 25% of patients did not
resume their daily activities and 20% of patients their leisure activ-
ities because of HETF.
Psychological tolerance
Sixty-nine per cent of patients were longing to have the tube
removed and 45% worried about accidental tube removal, espe-
cially during the night. One-third of patients were uncomfortable
about their body image. Feeding time was felt to be too long in
51% of patients although it was similar in average to the time 
(45 min) they spent for lunch or dinner before the disease
occurred. Sleeping disorders (in falling to sleep or accidental
waking) were mentioned by 13% of patients and the same propor-
tion reported depression since tube feeding. In these patients, the
emotional functioning was significantly (P = 0.022) lower scored
than in patients who did not express depression.
Changes in family and social relationships
Changes in relationships with family or close relations were
reported by 13–34% of patients. They mostly concerned improve-
ment in relationships with children (13%), spouse (28%), friends
(28%) and other family members (34%). This improvement was
considered as HETF-related by 7–13% of patients. On the other
hand, HETF was reported as totally preventing social or family
relationships in 15% of patients; it partially prevented relation-
ships such as participating in a lunch or a dinner at children or
family/friends house in 14% and 33% of patients respectively.
These figures were lower when applied to lunch or dinner at
patient’s home (9% and 16% respectively). Finally, 8% of patients
reported welcoming nobody because of HETF and 23% never
went out in public.
Changes in self-reported health status between day 7
and day 28
At day 28, 30 patients were interviewed. Of the remaining nine
patients, five had died of the disease, two patients had the tube
removed before day 28, one patient was rehospitalized at day 10 for
a period exceeding 3 weeks, and the last patient refused the second
interview. Overall results are given for these 30 patients in Table 3.
Over the study period, functional scores remained unchanged 
or slightly improved. Similar findings were observed for symptoms
(QLQ-C30) except for constipation which was significantly 
(P = 0.02) improved. In contrast, three specific symptom scores
(H&N35) significantly improved: coughing (P = 0.036), social
function (P = 0.03) and body image/sexuality (P = 0.014). No
solid conclusion could be made concerning the influence of therapy
on quality of life improvement since the number of patients under
therapy was limited (n = 5). No obvious differences existed,
however, between patients with or without therapy (data not
shown). The same observation applied to the following patient
subgroups: patients with newly diagnosed head and neck or
oesophageal cancer (n = 9), patients with relapse (n = 8) and
tumour-free patients with tumour-related complications (n = 13).
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Table 3 EORTC QLQ-C30 and H&N35 questionnaires for quality of life: variation of scores between day 7
and day 28 among 30 patients
Mean Mean
QLQ-C30 (n = 30) difference s.d. H&N-35 (n = 28) difference s.d.
Functional scalesa
Physical functioning 8 28
Role functioning –1 41
Emotional functioning 0 26
Cognitive functioning –1 23
Social functioning 5 26
Global health status/QoL 5* 16
Symptom scales/itemsb Symptom scales/itemsb
Fatigue –6 31 Swallowing 3 29
Nausea and vomiting 4 35 Nutritional aspects –2 20
Pain –4 28 Pain –5 18
Dyspnoea –2 35 Coughing –11** 26
Insomnia 3 38 Feeling ill –8 30
Appetite loss –7 41 Social function –16** 30
Constipation –14** 32 Speech –11* 26
Diarrhoea 5 39 Body image/sexuality –13** 23
Financial difficulties –6 25
aA positive difference of score = improvement of QoL. bA negative difference of score = improvement of
QoL. *P < 0.10, **P < 0.05.Changes in tolerance of HETF between day 7 and 
day 28
A significant (P = 0.016) improvement was observed for concomi-
tant mixed diet which was more often reported. However, it
concerned liquid (five patients) and grinding solid (three patients)
intake. In patients who had mixed diet at day 28, physical func-
tioning, emotional functioning and global health quality of life
scores did not significantly differ from those who had exclusive
HETF. At day 28, 43% of patients reported at least one diarrhoea
experience since hospital discharge. Overall, all other parameters
used to estimate the physical and psychological tolerance of HETF
remained unchanged over the study period.
Concordance between the H&N35 and the HETF
tolerance questionnaires
Overall, 15 items of the HETF tolerance questionnaire were a
priori used to define patients who were intolerant of the technique.
They concerned depression (one item), more distant family rela-
tionships (four items), HETF considered as an obstacle for going
out in public (one item), for visiting close relations (one item), for
welcoming home relations for a visit (one item), for receiving
home or going to close relations for lunch or dinner (seven items).
A patient was considered intolerant if one of the above items was
mentioned at day 28. This was observed in 16 (53%) out of 30
patients. These 16 patients presented a body image/sexuality score
significantly higher than that of the other patients (39.7 and 12.8
respectively; P = 0.004). Their social function score was also
higher (28.5 and 10.4 respectively; P = 0.055). In contrast, no rela-
tionship was observed between intolerance of the technique and
socio-demographic data, medical characteristics or feeding route
(nasogastric or gastrostomy tube).
DISCUSSION
The quality of life of patients with head and neck cancer or with
oesophageal cancer is not altered as measured over a 1-month
period of HETF although a substantial proportion (10–33%) of
patients report that the technique represents difficulty in family
and social life. Major complaints also concern diurnal and
nocturnal thirst, diarrhoea, body image and the length of time
before the tube is removed.
Our study is the first that prospectively assessed quality of life
of cancer patients with HETF. The study was made possible
because of a close participation of all individuals responsible for
patient care, in particular dieticians and nurses. Three quarters of
the patients completed the study including two assessments at a 3-
week interval. The questionnaires used included the generic, vali-
dated quality of life core questionnaire of the EORTC (QLQ-C30)
and its two specific modules on head and neck cancer (H&N35)
and on oesophageal cancer (OES24) (Patrick and Deyo, 1989;
Aaronson et al, 1993, 1994; Guyatt et al, 1995), and a specifically
developed questionnaire aiming at evaluating the tolerance of
HETF since no instrument was available. It is well established that
quality of life or related measures are better assessed using self-
administered questionnaires (Osoba, 1994). The HETF tolerance
questionnaire, although not validated, includes items that were
shown to correlate with items of the H&N35 module which might
indicate that questions included in the HETF tolerance question-
naire are relevant and well understood by the patients.
The relationship between HETF and quality of life has been
evaluated by interview in two studies (Nelson et al, 1986; Sami et
al, 1990). Improvement or no change in quality of life as a conse-
quence of HETF were observed in 88% (among 53 patients) and
75% (among 12 patients) of patients, including return to daily or
previous professional activities in a substantial proportion of them.
In these two studies, however, the proportion of patients with
nocturnal HETF was not specified. In general, studies only focus
on selected aspects of quality of life such as physical functioning,
symptoms, or psychological impact. In 1981, Rains reported that
six out of ten patients (including nine retired patients) had limited
physical activities although eight maintained daily activities
without the need of family help (Rains, 1981). The most frequently
reported symptoms concern nose and throat soreness and dryness,
and thirst (Padilla et al, 1979; Bruning et al, 1988). Our patients
rarely complain of the former symptoms which can reflect a better
tolerance of the material (tube) used. However, thirst remains a
major symptom while digestive complaints are limited (Padilla et
al, 1979). Diarrhoea is the most frequent digestive symptom but it
can be avoided by increasing the time of tube feeding. Since the
end of the study and to limit the proportion of patients suffering
from thirst, dieticians recommend that the same amount of caloric
intake be prescribed in three meals (instead of four per day) with
increasing water intake between meals.
An attempt to define patients intolerant of the technique using
depression or impairment in family or social relationships, ended
in classifying 53% of patients as intolerant. This classification
correlated well with the validated questionnaires used. Although
very strict, this classification was of no help in defining an ab
initio patient profile at risk of developing psychological intoler-
ance to the technique.
Changes in relationships with family and friends are infrequent
and when mentioned, mostly concern improvement. When an
impairment is observed, it generally concerns patients who
reported family problems prior to artificial feeding (Perl et al,
1980; Padilla and Grant, 1985). The psychological impact of
HETF can be summarized into two aspects: the emotional
response to artificial feeding and the psychological problems
related to the inability to eat. The emotional response to artificial
feeding depends on diagnosis and prognosis of cancer, and on
personality characteristics of patients and family members
involved. Peteet et al have described three emotional reactions that
can be observed in patients with HETF or home parenteral nutri-
tion: becoming more passive in demoralized patients, struggling
over artificial feeding in independent patients, and an extreme
preoccupation with eating and maintaining weight in very anxious
patients or families who express fears about dying (Peteet et al,
1981). Most of our patients could be grouped in the first category
although no information is available on their psychological charac-
teristics. The psychological problems related to the inability to eat
have been reported in patients with enteral as well as parenteral
nutrition. The inability to eat is a major complaint. It is also
considered by most patients as a major loss (Rains, 1981; Bruning
et al, 1988). Patients report that they feel excluded from events
where meals play a major part (Perl et al, 1980; Rains, 1981). They
complain of their inability to taste, chew and swallow food, to
drink and satisfy their appetite with certain foods (Bruning et al,
1988). It has been reported that patients do not become accus-
tomed to having a nasogastric tube and taking food through a tube
instead of through the mouth. This discomfort does not vary with
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a few patients tolerate badly HETF although all have reported no
change in physical discomfort over the study period. HETF
resulted in depression, mentioned by the patient himself, in 27% of
the patients. This proportion might be overestimated since HETF
was part of the initial therapy in 67% of patients, and a conse-
quence of complication in 33%.
All of these circumstances can induce depression per se,
although depression is commonly reported (23–40%) in series of
patients with head and neck cancer (Chaturvedi et al, 1996; List et
al, 1997). However, depressed patients expressed an emotional
functioning scale score significantly lower than that of other
patients. Nasogastric tube has been reported to be far less tolerated
than gastrostomy at such a level that some patients have expressed
the wish to replace the former by a parenteral nutrition catheter
(Srp et al, 1989). However, should the patients have the choice
between the two techniques, most elderly patients would prefer
HETF for two main reasons: no technical competence is required
and there is less fear of technical dysfunction. While for some
patients physical comfort is a priority, for others body image is
essential (Srp et al, 1989). In our study, patients considered intol-
erant had a body image/sexuality score which altered significantly
more than that of other patients, although no difference was found
between patients with a nasogastric tube and those with gastros-
tomy in contrast to the findings of Lees (1997).
Our short-term tube feeding population study demonstrates that
in patients with head and neck cancer or with oesophageal cancer,
HETF is a physically well tolerated technique. Only a limited
proportion of patients benefiting from this technique might need
psychological support after hospital discharge.
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